EB154/7
Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
Prevention and management of noncommunicable diseases, promotion of mental health and well-being, and treatment and care of mental health conditions
EB154/8
Draft global action plan for infection prevention and control
Draft global action plan and monitoring framework
EB154/8 Add.1
Draft global action plan on infection prevention and control
Draft global action plan and monitoring framework: minimum requirements for IPC programmes at national and health care facility levels
EB154/8 Add.2
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board
EB154/9
Immunization Agenda 2030
Progress towards global immunization goals and implementation of the Immunization Agenda 2030
EB154/10
End TB Strategy
Progress in implementing the global strategy and targets for tuberculosis prevention, care and control after 2015 (the End TB Strategy)
EB154/11
Road map for neglected tropical diseases 2021–2030
EB154/12
Acceleration towards the Sustainable Development Goal targets for maternal health and child mortality
EB154/13
Antimicrobial resistance: accelerating national and global responses
WHO strategic and operational priorities to address drug-resistant bacterial infections in the human health sector, 2025–2035
EB154/14
WHO’s work in health emergencies
Public health emergencies: preparedness and response
EB154/15
WHO’s work in health emergencies
Strengthening the global architecture for health emergency preparedness, prevention and response and resilience
EB154/16
Implementation of resolution WHA75.11 (2022)
EB154/29 Rev.1 Add.1
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board
EB154/30
Prevention of sexual exploitation, abuse and harassment
EB154/31
Evaluation: update and proposed workplan for 2024–2025
EB154/32
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Secretariat implementation plan on reform
EB154/33
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Strengthening WHO’s budgetary, programmatic and financing governance: follow-up to the implementation of decision EB152(15) (2023)
EB154/33 Add.1
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Proposals for improving the effectiveness of the WHO Governing bodies
EB154/33 Add.2
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Project plan: implementation of digital solutions for interactions between the Secretariat and Member States on matters related to the governing bodies
EB154/33 Add.3 Rev.1
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Cost recovery mechanisms for voluntary contributions – an update
EB154/33 Add.5
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board
EB154/34
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
EB154/34 Add.1
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Follow-up to decision WHA69(8) (2016), operative paragraph (10)
EB154/34 Add.2
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Proposed methodology for costing new initiatives/programmes
EB154/34 Add.3
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board
EB154/34 Add.4 Rev.1
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
EB154/34 Add.5
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board
EB154/35
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Process of handling and investigating potential allegations against WHO Directors-General
EB154/36
Engagement with non-State actors
Report on the implementation of the Framework of Engagement with Non-State Actors
EB154/37
Engagement with non-State actors
Non-State actors in official relations with WHO
EB154/37 Add.1
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board
EB154/38
Nomination and appointment of Regional Directors
Process for the election of Regional Directors
EB154/38 Add.1
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board
EB154/38 Add.2
Nomination and appointment of Regional Directors
Process for the election of Regional Directors
Note by the Legal Counsel
EB154/39
Provisional agenda of the Seventy-seventh World Health Assembly
EB154/40
Date and place of the 155th session of the Executive Board
EB154/41
Independent Expert Oversight Advisory Committee: membership renewal
Extension of terms of office and appointment of new members
EB154/42
Foundation committees and selection panels
EB154/43
Appointment of the Regional Director for the Eastern Mediterranean
EB154/44
Appointment of the Regional Director for South-East Asia
EB154/45
Appointment of the Regional Director for the Western Pacific
EB154/INF./4
Report of the Ombudsperson
Ombudsperson’s recommendations: progress on implementation
Diverse documents
EB154/DIV./1 Rev.1
List of members and other participants
Liste des membres et autres participants
MEMBERS, ALTERNATES AND ADVISERS
MEMBRES, SUPPLEANTS ET CONSEILLERS
The interpretation of proceedings serves to facilitate communication and does not constitute an authentic or verbatim record of the proceedings. Only the original speech is authentic.
